EKORENT
Provides loan financing for private medical practices, clinics and laboratories in the Czech Republic
Highlights
- New on EvolcAdded 2026-11-14
About EKORENT
EKORENT is a Czech credit company that finances the purchase, construction, renovation and modernization of private medical practices and laboratories. Its loans can also cover medical equipment, property and vehicles.
The company serves healthcare professionals and private medical facilities. It is a subsidiary of Banka CREDITAS and has operated in the Czech financial market since 1992; its registered seat is Prague.
Product: Loans for private medical practices and laboratories, including financing for equipment, premises, renovations and vehicles.
Jobs at EKORENT
Leadership
- Michal Šimůnek · jednatel společnostiSource: business register
- Petr Harcuba · jednatel společnostiSource: business register
- Zdenka Aoufová · vedoucí obchodního odděleníSource: company website
More fintech companies
Elanor
Payroll, HR and accounting outsourcing for mid-size and large employers in Central and Eastern EuropeElecto
Investment and financing intermediary in Prague with ČNB licences for consumer credit and main investment servicesepartners.cz
Financial advisory network giving its advisors client-planning, internal IT and training tools, plus consumer finance sites in CZ and SKEquity Consult
Financial asset management and advisory services for private clients, businesses and institutionsNew on EvolceRockets
Invests capital and e-commerce expertise in growth-oriented online retailers and their management teams
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Website resourcedeclared script/iframe or software asset
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.